Search

everythinglearnresearchcommunity

for

Search:↓

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Dutasteride makes alcohol less sedating and may lead to less drinking in men.

Finasteride reduces new brain cells in male mice, possibly causing depression.

Men with testicular cancer were less likely to experience baldness and severe acne.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Rats had lasting erectile problems after stopping a certain medication.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Male faces age with more wrinkles and hair loss, influenced by both body changes and environmental factors.

Finasteride use may lead to less alcohol consumption in men with lasting sexual side effects.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Taking spironolactone and linestrenol for androgen excess can lead to lower bone density in young women.

Leptin helps start the growth phase of hair.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

Finasteride may increase depression by reducing brain cell growth.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Finasteride reduces alcohol withdrawal severity and anxiety in mice, but may increase withdrawal severity in some cases.

Finasteride reduces response to stress and rewards, affecting behavior and mental health.

Dutasteride does not impair mental function in elderly men with enlarged prostate.

Finasteride and dutasteride reduce neurosteroid production, possibly helping treat glioblastoma.

Moderately high prolactin levels do not cause hair loss in women.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

New method measures finasteride in blood quickly and accurately.

Finasteride exposure harms tadpole reproduction and hormone balance.

RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.